share_log

AC Immune Analyst Ratings

Benzinga ·  Aug 7, 2023 06:12
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/07/2023 436.91% HC Wainwright & Co. → $16 Reiterates Buy → Buy
06/28/2023 436.91% HC Wainwright & Co. → $16 Reiterates Buy → Buy
05/01/2023 436.91% HC Wainwright & Co. → $16 Reiterates → Buy
04/19/2023 436.91% HC Wainwright & Co. → $16 Reiterates → Buy
03/17/2023 436.91% HC Wainwright & Co. → $16 Reiterates → Buy
07/11/2022 235.57% SVB Leerink $15 → $10 Maintains Outperform
12/20/2021 403.36% SVB Leerink $17 → $15 Maintains Outperform
03/24/2021 436.91% HC Wainwright & Co. $11 → $16 Maintains Buy
12/10/2019 269.13% HC Wainwright & Co. $8 → $11 Reiterates → Buy
02/01/2019 UBS Downgrades Buy → Neutral
11/13/2018 504.03% Leerink Swann → $18 Initiates Coverage On → Outperform

What is the target price for AC Immune (ACIU)?

The latest price target for AC Immune (NASDAQ: ACIU) was reported by HC Wainwright & Co. on August 7, 2023. The analyst firm set a price target for $16.00 expecting ACIU to rise to within 12 months (a possible 436.91% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for AC Immune (ACIU)?

The latest analyst rating for AC Immune (NASDAQ: ACIU) was provided by HC Wainwright & Co., and AC Immune reiterated their buy rating.

When is the next analyst rating going to be posted or updated for AC Immune (ACIU)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AC Immune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AC Immune was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.

Is the Analyst Rating AC Immune (ACIU) correct?

While ratings are subjective and will change, the latest AC Immune (ACIU) rating was a reiterated with a price target of $0.00 to $16.00. The current price AC Immune (ACIU) is trading at is $2.98, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment